上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于东睦新材料集团股份有限公司 2024 年年度股东会 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9、11、12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于东睦新材料集团股份有限公司 2024 年年度股东会 法律意见书 致：东睦新材料集团股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受东睦新材料集团股份有 限公司（以下简称"公司"）委托，就公司召开 2024 年年度股东会（以下简称 "本次股东会"）的有关事宜，根据《中华人民共和国公司法》（以下简称"《公 司法》"）、《上市公司股东会规则》等法律、法规和其他规范性文件以及《东 睦新材料集团股份有限公司章程》（以下简称"《公司章程》"）的有关规定， 出具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东会 ...

东睦新材料集团股份有限公司 股东会议事规则 东睦新材料集团股份有限公司 股东会议事规则 （2025年第1次修订） 第一章 总则 第一条 为规范东睦新材料集团股份有限公司（以下简称"公司"）行为，保证股东会依法 行使职权，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证 券法》（以下简称"《证券法》"）、《上市公司股东大会规则》（以下简称"《股东大会规则》"） 以及《东睦新材料集团股份有限公司》（以下简称"公司章程"）的规定，制定本规则。 第二条 公司应当严格按照法律、行政法规、公司章程及本规则的相关规定召开股东会，保 证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当勤勉尽责，确保 股东会正常召开和依法行使职权。 第三条 股东会应当在《公司法》、《股东大会规则》和公司章程规定的范围内行使职权。 第四条 股东会是公司的权力机构，依法行使下列职权： 股东会可以授权董事会对发行公司债券作出决议。除此之外，前款规定的股东会职权不得通 过授权的形式由董事会或其他机构和个人代为行使。 第五条 公司下列对外担保行为，须经股东会审议通过： （一）单笔担保额超 ...

聚粉末之力 创绿色未来 东睦新材料集团股份有限公司 章 程 （2025 年第 1 次修订） | 第一章 | 总则 2 | | | --- | --- | --- | | 第二章 | 经营宗旨和范围 | 3 | | 第三章 | 股份 3 | | | 第一节 | 股份发行 3 | | | 第二节 | 股份增减和回购 4 | | | 第三节 | 股份转让 5 | | | 第四章 | 股东和股东会 | 6 | | 第一节 | 股东 | 6 | | 第二节 | 股东会的一般规定 | 9 | | 第三节 | 股东会的召集 12 | | | 第四节 | 股东会的提案与通知 | 13 | | 第五节 | 股东会的召开 14 | | | 第六节 | 股东会的表决和决议 | 17 | | 第五章 | 董事会 | 22 | | 第一节 | 董事 | 22 | | 第二节 | 董事会 24 | | | 第六章 | 总经理及其他高级管理人员 33 | | | 第七章 | 监事会 | 38 | | 第一节 | 监事 | 38 | | 第二节 | 监事会 39 | | | 第八章 | 财务会计制度、利润分配和审计 42 | | | 第一节 ...

东睦新材料集团股份有限公司 董事会议事规则 东睦新材料集团股份有限公司 董事会议事规则 （2025 年第 1 次修订） 第一章 总 则 第一条 为健全和规范东睦新材料集团股份有限公司（以下简称"公司"）董事会议事和决策 程序，保证公司董事会依法行使职权，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司治理准则》、《上海证券交易所股票上市规则》以及《东睦新材料集团股份有限公司》 （以下简称"公司章程"）的有关规定，并结合本公司的实际情况，制定本规则。 第二条 董事会是公司经营管理的决策机构，维护公司和全体股东的利益，负责公司发展目标 和重大经营活动的决策。 第三条 制定本议事规则的目的是规范公司董事会议事程序，提高董事会工作效率和科学决策 水平。 第四条 公司董事会对股东会负责。 董事会由 9 名董事组成，其中独立董事 3 人，设董事长 1 人，副董事长 1 人。 董事由股东会选举或更换，任期 3 年。董事任期届满，可连选连任。董事在任期届满以前， 股 东会可以决议解任董事，决议作出之日解任生效。无正当理由，在任期届满前解任董事的，该董 事可以要求公司予以赔偿。 董事任期从就任之日起计算，至 ...

Financial Performance - The company's operating revenue for Q1 2025 reached CNY 1,459,313,194.63, representing a year-on-year increase of 32.41% compared to CNY 1,102,132,227.35 in the same period last year[3] - Net profit attributable to shareholders was CNY 111,698,354.75, up 37.61% from CNY 81,171,485.47 in the previous year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 105,324,295.64, reflecting a 39.96% increase from CNY 75,252,950.22 year-on-year[3] - The basic earnings per share increased to CNY 0.18, a rise of 38.46% compared to CNY 0.13 in the same period last year[3] - The weighted average return on equity improved to 3.90%, an increase of 0.74 percentage points from 3.16%[3] - Total operating revenue for Q1 2025 reached ¥1,459,313,194.63, a 32.6% increase from ¥1,102,132,227.35 in Q1 2024[20] - Net profit for Q1 2025 was ¥146,447,501.96, representing a 65.4% increase compared to ¥88,559,772.49 in Q1 2024[21] - Earnings per share for Q1 2025 were ¥0.18, compared to ¥0.13 in Q1 2024[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 7,854,245,434.83, up 4.08% from CNY 7,546,622,963.72 at the end of the previous year[4] - Total assets increased to ¥7,854,245,434.83 in Q1 2025 from ¥7,546,622,963.72 in Q1 2024, reflecting a growth of 4.1%[17] - Total liabilities rose to ¥4,456,137,134.59 in Q1 2025, up from ¥4,285,120,831.07 in Q1 2024, indicating a 4.0% increase[17] - Non-current liabilities totaled ¥2,621,917,677.11 in Q1 2025, compared to ¥2,426,778,978.26 in Q1 2024, marking an 8.0% increase[17] Cash Flow - The cash inflow from operating activities for Q1 2025 was ¥932,199,981.93, an increase of 15.8% compared to ¥804,876,503.86 in Q1 2024[24] - The net cash flow from operating activities for Q1 2025 was ¥105,089,685.63, up 28.5% from ¥81,854,158.96 in Q1 2024[25] - The cash outflow for investing activities in Q1 2025 was ¥21,420,171.64, a decrease of 45.5% compared to ¥39,302,882.59 in Q1 2024[25] - The net cash flow from financing activities for Q1 2025 was ¥214,212,554.88, a significant improvement from a net outflow of ¥20,521,445.81 in Q1 2024[25] - The total cash and cash equivalents at the end of Q1 2025 amounted to ¥593,400,610.12, compared to ¥271,290,170.37 at the end of Q1 2024[26] - The cash inflow from financing activities in Q1 2025 was ¥466,000,000.00, compared to ¥130,800,000.00 in Q1 2024, indicating a substantial increase[25] Shareholder Information - The total number of common shareholders at the end of the reporting period was 43,633[9] - The company plans to distribute a cash dividend of RMB 0.30 per share, totaling approximately RMB 184,915,043.10, which represents 46.58% of the net profit attributable to shareholders for the year 2024[13] Business Operations - The main business revenue for the company reached CNY 1.45 billion, with significant contributions from MIM technology, which saw a 65.86% year-on-year growth[4] - The company issued approximately CNY 21.65 million in annual bonuses for 2024 during the reporting period[4] - The company reported accounts receivable of RMB 1,437,495,277.71 as of March 31, 2025, slightly down from RMB 1,453,799,119.16 at the end of 2024[15] - The long-term equity investments remained stable at RMB 257,751,869.07 compared to RMB 257,593,386.38 as of December 31, 2024[15] Acquisition and Regulatory Matters - The company is in the process of acquiring shares of Shanghai Fuchi High-Tech Co., Ltd., with the transaction involving both cash and stock issuance, subject to regulatory approvals[11] - The company’s total liabilities and equity are still under review as part of the ongoing audit and assessment for the acquisition transaction[12] - The company’s board meetings have approved significant adjustments to the acquisition plan, which may impact the financial metrics of the involved assets by over 20%[11] - The company has not engaged in any share lending activities through margin trading or stock borrowing as of the reporting date[11] Expenses - Total operating costs for Q1 2025 were ¥1,320,457,891.85, up 29.6% from ¥1,018,844,011.22 in Q1 2024[20] - The company reported a decrease in financial expenses from ¥27,679,747.81 in Q1 2024 to ¥18,004,938.19 in Q1 2025[21] - Research and development expenses increased to ¥79,363,794.57 in Q1 2025 from ¥76,582,948.95 in Q1 2024, showing a growth of 3.7%[21] Inventory and Current Assets - As of March 31, 2025, the total current assets amounted to RMB 3,631,069,503.83, an increase from RMB 3,268,562,003.31 as of December 31, 2024, reflecting a growth of approximately 11.1%[15] - The cash and cash equivalents increased significantly to RMB 616,713,610.12 from RMB 317,522,345.88, representing a growth of about 94.3%[15] - The total inventory decreased to RMB 1,064,587,956.72 from RMB 1,204,726,557.42, indicating a decline of approximately 11.6%[15]

东睦股份（600114）公告，2025年第一季度营收为14.59亿元，同比增长32.41%；净利润为1.12亿元， 同比增长37.61%。 ...

Core Viewpoint - Dongmu Co., Ltd. plans to acquire a 34.75% stake in Shanghai Fuchi through a combination of issuing shares and cash payments, while also raising supporting funds [1][2] Group 1: Transaction Details - The transaction involves five parties: Yuan Zhi Xing Huo, Zhong Wei, Chuang Jing Investment, Ningbo Hua Guan, and Ningbo Fu Jing [1] - The specific transaction price will be determined based on an asset evaluation report from a legally compliant evaluation agency [1] - The issuance price for the shares is set at 14.99 yuan per share [1] - The company aims to raise supporting funds not exceeding 100% of the transaction price, with the total number of shares issued not exceeding 30% of the total share capital post-transaction [1][2] Group 2: Use of Funds - The raised funds will be allocated for cash payments for the transaction, project construction of the target company, intermediary fees, and to supplement the liquidity of the listed company [2] - The proportion of funds used to supplement liquidity will not exceed 25% of the transaction price or 50% of the total raised funds [2] Group 3: Company Ownership and Financial Impact - Prior to the transaction, Dongmu Co. holds a 64.25% stake in Shanghai Fuchi, which will increase to 99.00% post-transaction [2] - The transaction does not constitute a major asset restructuring or a change in control, as the company remains without a controlling shareholder [2] Group 4: Financial Performance of Shanghai Fuchi - Shanghai Fuchi is projected to achieve revenues of 1,035.73 million yuan in 2023 and 1,977.44 million yuan in 2024, with net profits of -55.62 million yuan in 2023 and 166.96 million yuan in 2024 [3][4] - The financial data indicates a significant turnaround in profitability from a loss in 2023 to a profit in 2024 [3][4] Group 5: Dongmu Co. Financial Data - Dongmu Co. reported revenues of 5,142.99 million yuan in 2024, up from 3,861.08 million yuan in 2023 [5] - The net profit for 2024 is projected at 468.54 million yuan, compared to 194.16 million yuan in 2023 [5] - The cash flow from operating activities for 2024 is expected to be 351.92 million yuan, an increase from 295.17 million yuan in 2023 [5]

Group 1: Aier Eye Hospital - In 2024, Aier Eye Hospital achieved an outpatient volume of 16.94 million, a year-on-year increase of 12.14% [1] - The company reported a total revenue of 20.98 billion yuan, reflecting a growth of 3.02% compared to the previous year [2] - The net profit attributable to shareholders was 3.56 billion yuan, up by 5.87% year-on-year [2] - The company introduced several advanced medical technologies and products, including the INTENSITY™ intraocular lens and new dry eye treatment technology [1][3] Group 2: Tonghuashun - Tonghuashun reported a revenue of 4.19 billion yuan in 2024, marking a 17.47% increase from the previous year [5] - The net profit attributable to shareholders reached 1.82 billion yuan, a significant growth of 30% year-on-year [4][5] - The increase in revenue and profit was primarily driven by a recovery in the securities market and rising demand for financial information services [4] Group 3: Yiwei Lithium Energy - Yiwei Lithium Energy achieved a revenue of 1.28 billion yuan in Q1 2025, with a net profit of 110.11 million yuan, reflecting a 16.60% increase in net profit [7] - The company reported a significant increase in the shipment of energy storage batteries, with a year-on-year growth of 80.54% [8] - The company is expanding into emerging markets such as eVTOL and drones, with ongoing projects and production facilities being established [9] Group 4: Huadong Medicine - Huadong Medicine reported a revenue of 10.74 billion yuan in Q1 2025, a 3.12% increase year-on-year [10] - The net profit attributable to shareholders was 914.71 million yuan, up by 6.06% compared to the same period last year [11] - The company achieved its highest historical level of net profit excluding non-recurring gains and losses, reaching 897.34 million yuan [10] Group 5: Muyuan Foods - Muyuan Foods reported a revenue of 36.06 billion yuan in Q1 2025, a year-on-year increase of 37.26% [17] - The company turned a profit with a net profit of 44.91 billion yuan, compared to a loss of 23.79 billion yuan in the same period last year [18] - The significant growth was attributed to increased pig prices and sales [17] Group 6: China Aluminum - China Aluminum reported a revenue of 55.78 billion yuan in Q1 2025, with a net profit of 3.54 billion yuan, reflecting a year-on-year increase of 58.78% [21] - The company successfully managed market price fluctuations, resulting in increased product sales and profits [21] Group 7: Hengrui Medicine - Hengrui Medicine achieved a revenue of 72.06 billion yuan in Q1 2025, a 20.14% increase year-on-year [22] - The net profit attributable to shareholders was 18.74 billion yuan, up by 36.9% compared to the previous year [22] - The increase in profit was significantly influenced by a licensing payment received during the reporting period [22] Group 8: Bull Group - Bull Group reported a revenue of 16.83 billion yuan in 2024, reflecting a 7.24% increase year-on-year [13] - The net profit attributable to shareholders was 4.27 billion yuan, a growth of 10.39% compared to the previous year [13] - The company experienced growth in its electrical connection and smart lighting businesses, as well as rapid development in its new energy sector [14]

东睦新材料集团股份有限公司独立董事 关于发行股份及支付现金购买资产并募集配套资金暨关联交易 有关事项的独立意见 东睦新材料集团股份有限公司（以下简称"公司"）拟以发行股份及支付 现金的方式购买上海富驰高科技股份有限公司（以下简称"上海富驰"） 34.75%股权（以下简称"标的资产"）并募集配套资金（以下简称"本次交易" ）。 根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民 共和国证券法》（以下简称"《证券法》"）《上海证券交易所股票上市规则》 （以下简称"《上市规则》"）《上市公司重大资产重组管理办法》（以下简 称"《重组管理办法》"）《上市公司证券发行注册管理办法》（以下简称" 《证券发行注册管理办法》"）等有关法律、法规、规范性文件以及《公司章 程》的相关规定，公司独立董事对公司提供的本次交易所涉及事项的相关材料 进行了认真、全面的审查，听取了公司有关人员对本次交易情况的详细介绍， 基于独立判断的立场，就本次交易的相关事项发表如下独立意见： 3 述或重大遗漏，有效地保护了公司及投资者的利益，符合相关法律、法规及规 范性文件的规定。 4、截至目前，本次交易相关的审计、评估工作尚未完成，本次 ...